Individuals with mutations in DICER1 are at an increased risk of developing RMS and many other cancer types, including pleuropulmonary blastoma (the highest cancer risk), cystic nephroma, thyroid cancer, and ovarian Sertoli–Leydig cell tumors [69]. Here, DICER1 is linked to pleuropulmonary blastoma.